The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
We're proud to receive a 2025 CDMO Leadership Award in the “Small Molecule Dosage Form - Global" category.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
mRNA is being explored as a therapeutic strategy for a variety of clinical applications, including infectious disease, protein replacement, and immuno-oncology, among others.
But despite its inherent advantages, several challenges still exist, including:
- Optimizing mRNA stability and protein expression
- Developing production and purification processes
- Designing an efficient therapeutic delivery vehicle
- Balancing the innate immune system response
- Obtaining the intended therapeutic response
Our interactive article explores each industry challenge in detail and examines avenues to overcome them.